Linkage study of Catechol-O-Methyltransferase and attention-deficit hyperactivity disorder
- 15 December 1999
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 88 (6) , 710-713
Abstract
Attention-deficit hyperactivity disorder is the most common child psychiatric disorder with a prevalence rate in an Ontario study of 9% in boys and 3% in girls [Szatmari et al., 1989]. This disorder is characterized by problems in the areas of attention, overactivity, impulse control, and distractibility. Strong evidence for a genetic component has been provided from twin, family, and adoption studies [for review see Levy et al., 1998] and molecular genetic studies are in progress by several groups worldwide. The Catechol-O-Methyltransferase (COMT) gene is an interesting candidate for ADHD as it is involved in the breakdown of dopamine and norepinephrine, neurotransmitters strongly implicated in the etiology of ADHD. In addition, children with velo–cardio–facial syndrome, a deletion syndrome of the chromosomal region 22q11 where the COMT gene has been localized, often have symptoms of ADHD suggesting this gene may have an etiological role in ADHD. In this study, we have tested for linkage in ADHD families using the functional polymorphism at codon 158 that determines COMT activity [Lachman et al., 1996] and analyzed the data with the transmission disequilibrium test (TDT). A total of 77 nuclear families collected from Toronto were genotyped. We find no evidence for linkage of this polymorphism and ADHD in our sample. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 88:710–713, 1999.Keywords
This publication has 21 references indexed in Scilit:
- Catechol- O -methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behaviorProceedings of the National Academy of Sciences, 1998
- Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorderMolecular Psychiatry, 1998
- Identification of Sequence Variants and Analysis of the Role of the Catechol-O-Methyl-Transferase Gene in Schizophrenia SusceptibilityBiological Psychiatry, 1998
- A New Self-Report Scale for Assessment of Adolescent Psychopathology: Factor Structure, Reliability, Validity, and Diagnostic SensitivityJournal of Abnormal Child Psychology, 1997
- Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorderProceedings of the National Academy of Sciences, 1997
- Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndromeAmerican Journal of Medical Genetics, 1996
- No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activityAmerican Journal of Psychiatry, 1996
- Evaluation of the Revised Ontario Child Health Study ScalesJournal of Child Psychology and Psychiatry, 1993
- Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2Genomics, 1992
- Human liver catechol-O-methyltransferase pharmacogeneticsClinical Pharmacology & Therapeutics, 1990